Theme 1: Accelerating the Drug Development Process through Formulation and Delivery Strategies
Formulation and delivery strategies that can accelerate the drug development process may largely improve efficiency and shorten the time to market for patients in need. The theme covers a variety of strategies and current advancements on accelerating formulation development, such as high throughput screening; critical quality attribute identification; advanced evaluation tools for early-stage development; developability assessments; risk-balanced development strategies; AI and modelling tools to enable formulation development; in vitro and in vivo correlation; site- and disease-specific drug delivery; platform processes and technologies; multifunctional micro- and nano-delivery systems; modified release; long-acting implants; and related topics, for chemical, biomolecular, and new modality drugs.
Theme 2: Enabling Excipients and Approaches for Advancing Formulation and Delivery
The increasing complexity of new molecular entities drives the need for enabling excipients. Excipients impact a wide range of performance characteristics. This theme explores enabling excipients such as new small-molecule, lipid, polymeric, and peptidic excipients to serve as enteric coatings; permeability enhancers; mucoadhesives; enzyme inhibitors; transport enhancers; cell penetrators; tight-junction modulators; complex formulation stabilizers; and related topics. The theme also covers the excipients for implantable delivery devices and drug-device combinations and formulation technologies that are used based on the types of excipients -- i.e., microencapsulation, spray drying, nanoencapsulation technologies, excipient material properties, and drug-excipient physical and chemical interactions.
Theme 3: Formulation and Delivery for Patient Centric Product Development
Innovative patient-centric development has been increasingly explored to enhance patient convenience, comfort, and compliance. This theme includes formulation and development strategies that can address technical challenges and lead to the ultimate clinical success of patient-centric products, such as drug-device combination products (e.g. autoinjectors or patch pumps) enabling patient self-administration; delivery technologies allowing subcutaneous delivery of large volumes; and non-intravenous routes of administration (e.g. intranasal, pulmonary, or intradermal). The theme also includes strategies for efficient introduction of novel formulation and delivery technologies to deliver patient-centric products at market launch, such as enhanced communication between functional areas; early implementation of the quality target product profile process; and mutual understanding of the different technical challenges encountered between discovery, clinical, CMC organizations, and patients, among others.
Find Your Community!
Join one of the AAPS Community Membership Meetings to learn about an AAPS Community and its activities. You will have the opportunity to meet the leadership, network with colleagues, and discuss the latest scientific discoveries. These meetings are open to all registrants.
Monday, October 23, 2023
• AAPS Biomarkers & Precision Medicine Community Membership Meeting
• AAPS Chemistry, Manufacturing, & Controls (CMC) Membership Meeting
• AAPS Drug Transport Community Membership Meeting
• AAPS Gene & Cell Therapy Products Community Membership Meeting
• AAPS Global Health Community Membership Meeting
• AAPS In Vitro Release & Dissolution Testing Community Membership Meeting
• AAPS Inhalation & Nasal Community Membership Meeting
• AAPS Ocular Drug Delivery & Disposition Community Membership Meeting
• AAPS Preformulation & Formulation Design/Development Community Membership Meeting
• AAPS Regulatory Sciences Community Membership Meeting
• AAPS Stability Community Membership Meeting
• AAPS Topical & Transdermal Community Membership Meeting
Tuesday, October 24, 2023
• AAPS Bioanalytical Community Membership Meeting
• AAPS Excipients Community Membership Meeting
• AAPS Lipid-Based Drug Delivery Systems Community Membership Meeting
• AAPS Manufacturing Science & Engineering Community Membership Meeting
• AAPS Nanotechnology Community Membership Meeting
• AAPS Pharmacokinetics, Pharmacodynamics, & Drug Metabolism Community Membership Meeting
Coffee and Conversation With the Fellows Communications Task Force
Hosted by Committee Chair Dale Eric Wurster, Ph.D., FAAPS
The AAPS Fellows Communications Task Force is assessing communications between AAPS and the Fellows, and among the Fellows too! Take this opportunity to share your thoughts with the task force over a cup of coffee. Open to AAPS Fellows only.
Monday, October 23
• 8:00 am – 9:00 am
• 2:30 pm – 3:00 pm
2023 AAPS PharmSci 360 Exhibit and Sponsorship Opportunities
Exhibiting and sponsorship opportunities are now available! Booth and non-booth packages are available to meet the business goals of scientific leadership, lead generation, brand awareness, and product/service demonstration. To learn more, go to www.aapspharmsci360.org, or contact Robin Hatfield at SalesAAPS@ntpevents.com.